ETF DAILY NEWS

Roth Capital Issues Negative Estimate for TLSI Earnings

TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Free Report) – Equities research analysts at Roth Capital cut their Q2 2025 earnings estimates for shares of TriSalus Life Sciences in a research report issued to clients and investors on Wednesday, May 21st. Roth Capital analyst J. Wittes now anticipates that the company will post earnings per share […]

May 24, 2025 - 06:24
 0
Roth Capital Issues Negative Estimate for TLSI Earnings
TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Free Report) – Equities research analysts at Roth Capital cut their Q2 2025 earnings estimates for shares of TriSalus Life Sciences in a research report issued to clients and investors on Wednesday, May 21st. Roth Capital analyst J. Wittes now anticipates that the company will post earnings per share […]
Read More

Tags:

Previous Article

What is Cormark’s Forecast for TSE:LB Q2 Earnings?

Next Article

Zacks Research Has Negative View of S&P Global Q2 Earnings

Related Posts

B. Riley Has Lowered Expectations for Hyperfine (NASDAQ:HYPR) Stock Price

B. Riley Has Lowered Expectations for Hyperfine (NASDAQ...

May 17, 2025  0

Nomura Holdings Inc. Makes New $519,000 Investment in Spire Inc. (NYSE:SR)

Nomura Holdings Inc. Makes New $519,000 Investment in S...

May 22, 2025  0

Janus Henderson Group PLC Purchases New Position in Astera Labs, Inc. (NASDAQ:ALAB)

Janus Henderson Group PLC Purchases New Position in Ast...

May 21, 2025  0